¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"committed stem cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
cell dedifferentiation
¼¼Æ÷Å»ºÐÈ
cell division
¼¼Æ÷ºÐ¿
cell envelope
¼¼Æ÷²®Áú, ¼¼Æ÷ÇǸ·
cell fusion
¼¼Æ÷À¶ÇÕ
cell inclusion
¼¼Æ÷Æ÷ÇÔ¹°, ¼¼Æ÷ºÀÀÔü
cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ë
cell labeling technique
¼¼Æ÷Ç¥Áö±â¹ý
cell lethality
¼¼Æ÷Ä¡»çÀ²
cell line
¼¼Æ÷ÁÖ, ¼¼Æ÷°è
cell loss
¼¼Æ÷¼Ò½Ç
cell mass
¼¼Æ÷µ¢ÀÌ, ¼¼Æ÷±«
cell membrane
¼¼Æ÷¸·
cell membrane permeability
¼¼Æ÷¸·Åõ°ú¼º
cell organelle
¼¼Æ÷¼Ò±â°ü
cell respiration
¼¼Æ÷È£Èí
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
cell agar plate
¼¼Æ÷¿ì¹«ÆòÆÇ
cell color ratio
ÀûÇ÷±¸»ö¼Òºñ
cell labeling technique
¼¼Æ÷Ç¥Áö±â¹ý
cell membrane permeability
¼¼Æ÷¸·Åõ°ú¼º
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cell-associated virus
¼¼Æ÷ºÎÂø¹ÙÀÌ·¯½º
cell-mediated cytolysis
¼¼Æ÷¸Å°³¼¼Æ÷¿ëÇØ
cell-mediated cytotoxicity
¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
cell-mediated hypersensitivity
¼¼Æ÷¸Å°³°ú¹Î
cell-mediated immunity
¼¼Æ÷¸Å°³¸é¿ª
cell-mediated reaction
¼¼Æ÷¸Å°³¹ÝÀÀ
cell-mediated response
¼¼Æ÷¸Å°³¹ÝÀÀ
cell-mediated immunodeficiency syndrome
¼¼Æ÷¸Å°³¸é¿ª°áÇÌÁõÈıº
cell-mediated lympholysis test
¼¼Æ÷¸Å°³¸²ÇÁ±¸¿ëÇØ½ÃÇè
centroacinar cell
»ù²Ê¸®Á߽ɼ¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
accessory cell
º¸Á¶¼¼Æ÷, ºÎ¼ö¼¼Æ÷
acidophilic cell
È£»ê¼º¼¼Æ÷
acinar cell
¼±Æ÷ ¼¼Æ÷(àÍøàá¬øà)
acinar cell
¼±¹æ¼¼Æ÷(¡á¬øà)
acinic cell carcinoma
¼±¹æ¼¼Æ÷¾ÏÁ¾(¡á¬øàäßðþ)
acinic cell tumor
¼±¹æ¼¼Æ÷Á¾(¡á¬øàðþ)
activation, polyclonal B cell
´Ù¼¼Æ÷±º B¼¼Æ÷Ȱ¼º, ¿©·¯¹«¸® B¼¼Æ÷Ȱ¼º
adamantinoid basal cell carcinoma
¹ý¶û Á¾¾ç(ÛöÕË ðþåÆ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
adcc(antibody dependent cell mediated cytotoxicity)
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øàØÚË¿á¬øàÔ¸àõ)
adenoid basal cell carcinoma
¼±»ó(àÍßÒ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
adenoid squamous cell carcinoma
¼±»ó ÆíÆò »óÇǼ¼Æ÷(àÍßÒ ø·øÁ ß¾ù«á¬øà) ¾Ï
adult T Cell leukemia virus
¼ºÀÎ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
adult T cell leukemia virus (HTLV)
¼ºÀÎT¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
adult t-cell leukemia/lymphoma
¼º¼÷ T-¼¼Æ÷ ¹éÇ÷º´/¸²ÇÁÁ¾(à÷âÙ¡á¬øà ÛÜúìÜ»/¡ðþ)
alpha cell
¾ËÆÄ¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
alpha cell
¾ËÆÄ¼¼Æ÷(¡á¬øà)
alpha cell tumor
¾ËÆÄ ¼¼Æ÷Á¾(¡á¬øàðþ)
amacrine cell
¾Æ¸¶Å©¸° ¼¼Æ÷
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
analyzer for cell count
¼¼Æ÷¼öºÐ¼®±â
aneuploid cell
À̼ö¼º¼¼Æ÷
angiotropic (intravascular) large cell lymphoma
Ç÷°ü¿µ¾ç¼º(Ç÷°ü³»)´ë¼¼Æ÷¸²ÇÁÁ¾
anitschkow cell
¾Æ´ÏÄ¡ÄÚ¿ì¼¼Æ÷(¡á¬øà)
annular elastotic giant cell granuloma
ȯ»ó ź·Â ¼¶À¯¼º °Å´ë¼¼Æ÷ À°¾ÆÁ¾
anoxic cell
¹«»ê¼Ò¼¼Æ÷
anti-idiotypic T suppressor cell
Ç×°³º°Æ¯ÀÌÇü ¾ïÁ¦T¼¼Æ÷
antibody dependent cell mediated cytotoxicity
Ç×üÀÇÁ¸ ¼¼Æ÷¸Å°³ ¼¼Æ÷µ¶¼º.
antibody forming cell
Ç×ü»ý»ê¼¼Æ÷(ù÷ô÷ßæß§á¬øà).
antibody producing cell
Ç×ü»ý»ê¼¼Æ÷
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½